Clinical Significance of β-Tricalcium Phosphate and Polyphosphate for Mastoid Cavity Obliteration during Middle Ear Surgery: Human and Animal Study

이한빈; 임혜진; 조민혁; 양석민; 박기현; 박훈이; 정연훈

추천

검색

자료유형: 학술저널

저자정보: 이한빈 임혜진 조민혁 양석민 박기현 박훈이 정연훈

저널정보: 대한이비인후과학회 Clinical and Experimental Otorhinolaryngology Clinical and Experimental Otorhinolaryngology 제6권 제3호

발행연도: 2013.1

수록면: 127 - 134 (8page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objectives. Mastoid obliteration is used to obliterate the mastoid cavity following a mastoidectomy or to prevent the formation of a retraction pocket. This study evaluated the effectiveness of β-tricalcium phosphate and polyphosphate (β-TPP) for mastoid obliteration in middle ear surgeries in prospective human and animal studies. Methods. Twenty patients with chronic otitis media underwent mastoid obliteration using β-TPP after a intact canal wall mastoidectomy or simple mastoidectomy. The clinical data were prospectively evaluated including: the diagnosis,temporal bone computed tomography (TBCT), otoscopic findings, pure tone audiogram, and complications. In the animal experiment, β-TPP was applied into the right bulla in five rats, and the opposite bulla was used as the control in the non-obliterated state. The skulls of five other rats were drilled out and the holes were obliterated with β-TPP. TBCT were obtained at 3, 6, and 9 months after the obliteration and histologic analysis was done at 3 and 9 months after surgery. Results. In the human study, fourteen TBCTs were obtained at 12 months after the surgery. All demonstrated no bone resorption in the obliterated mastoids. Among the 15 cases displaying retracted tympanic membranes preoperatively,11 showed no retraction, 2 showed retraction postoperatively, 1 was lost to follow-up and 1 was a case of postoperative wound infection. Among 20 cases, one case developed a postoperative infection that necessitated a second operation. Sixteen underwent ossiculoplasty; hearing improvements were obtained in 15 cases and 1 case showed decreased hearing. In the animal study, new bone formation without significant bone resorption in the radiologic and histologic findings were noted in both the skull and bulla groups. Conclusion. Although β-TPP is a foreign material having the possibility of infection, mastoid obliteration with it can be a treatment option in middle ear surgeries to prevent retraction pockets or the recurrence of diseases.

#Chronic otitis media #Cholesteatoma #Mastoidectomy #Treatment #Recurrence #Prevention

참고문헌 (26)

참고문헌 신청

/ 1995 / Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. American Academy of Otolaryngology-Head and Ne

Ambard AJ / 2006 / Calcium phosphate cement: review of mechanical and biological properties / J Prosthodont 15 (5) : 321 ~ 328

Black B / 1998 / Mastoidectomy elimination: obliterate, reconstruct, or ablate? / Am J Otol 19 (5) : 551 ~ 557

Dornhoffer JL / 1999 / Surgical modification of the difficult mastoid cavity / Otolaryngol Head Neck Surg 120 (3) : 361 ~ 367

Estrem SA / 1999 / Hydroxyapatite canal wall reconstruction/ mastoid obliteration / Otolaryngol Head Neck Surg 120 (3) : 345 ~ 349